Iltar, U. Et Al. 2022. Comparison the Clinical Features of Newly Diagnosed Multiple Myeloma Patients According to CD23 Expression Status. ACTA ONCOLOGICA TURCICA , vol.55, no.2 , 103-108.

Iltar, U., Salim, O., Ulas, T., Berker Karauzum, S., Aydin, C., & Undar, L., (2022). Comparison the Clinical Features of Newly Diagnosed Multiple Myeloma Patients According to CD23 Expression Status. ACTA ONCOLOGICA TURCICA , vol.55, no.2, 103-108.

Iltar, UTKU Et Al. "Comparison the Clinical Features of Newly Diagnosed Multiple Myeloma Patients According to CD23 Expression Status," ACTA ONCOLOGICA TURCICA , vol.55, no.2, 103-108, 2022

Iltar, UTKU Et Al. "Comparison the Clinical Features of Newly Diagnosed Multiple Myeloma Patients According to CD23 Expression Status." ACTA ONCOLOGICA TURCICA , vol.55, no.2, pp.103-108, 2022

Iltar, U. Et Al. (2022) . "Comparison the Clinical Features of Newly Diagnosed Multiple Myeloma Patients According to CD23 Expression Status." ACTA ONCOLOGICA TURCICA , vol.55, no.2, pp.103-108.

@article{article, author={UTKU ILTAR Et Al. }, title={Comparison the Clinical Features of Newly Diagnosed Multiple Myeloma Patients According to CD23 Expression Status}, journal={ACTA ONCOLOGICA TURCICA}, year=2022, pages={103-108} }